The World Health Summit 2025 delivered a clear message: global health systems are under pressure because we treat disease too late, not because prevention is impossible. For cardiovascular disease (CVD) and inherited lipid disorders, the summit’s conclusions strongly reinforce the need for earlier detection, stronger primary care, and policies that support long-term prevention.
Speakers across sessions highlighted overwhelming evidence: prevention delivers major health and economic returns, yet remains chronically underfunded. Early screening for cholesterol, hypertension, and inherited lipid disorders can dramatically reduce CVD risk and relieve health system pressure.
For our community, this means pushing for national adoption of family-based and genetic screening, and integrating lipid testing into routine preventive care.
UNICEF, WHO, and others stressed that lifelong cardiovascular risk is shaped early. Diet, physical activity, air quality, and safe environments influence heart and metabolic health long before adulthood.
This reinforces the importance of early diagnosis of inherited lipid disorders like FH, alongside child- and family-focused prevention strategies.
From liver health to cardiovascular disease, the summit highlighted a shift toward precision prevention — using genetics, biomarkers, imaging, and AI to identify risk early and act proactively.
For inherited lipid disorders, this approach is already central: early identification, monitoring across the life course, and tailored interventions for families.
The call to strengthen primary healthcare was consistent across WHS. Routine checks for blood pressure, cholesterol, and metabolic risk—supported by digital tools—are essential to reducing premature CVD deaths.
For lipid disorder communities, primary care is key to early detection and continuous management
The upcoming EU Cardiovascular Health Plan puts prevention and early detection at the centre of European policy. Its emphasis on “knowing your numbers,” digital tools, and routine checks aligns directly with the needs of people living with FH, Lp(a), and related conditions.
WHS speakers highlighted persistent gaps in women’s cardiovascular care: later diagnoses, misinterpreted symptoms, and limited participation in clinical research.
For inherited lipid disorders, sex-specific risk and care—especially during pregnancy and menopause—must become standard practice.
Climate, air pollution, food systems, and inequality were recognised as major contributors to cardiovascular and metabolic diseases. Effective prevention requires whole-of-society action, from healthier cities to stronger health literacy, not just clinical interventions.
WHS 2025 underscored that sustainable health systems depend on prevention, early detection, and equitable access to care. For the cardiovascular and inherited lipid disorders community, the path forward is clear:
If prevention becomes the backbone of policy and practice, we can change the trajectory of cardiovascular disease and protect future generations from preventable risks.
Read the full report here.